Pat Hughes is currently the Chief Commercial Officer at Cluepoints and has been in the industry for over 20 years. In this podcast, Pat discusses his view on the possible implications of Covid-19 on RBM and the wider pharmatech market.

For more information on Pat Hughes and Cluepoints, please click here.

Listen to the Podcast below: